Chr. Hansen Holding A/S

Chr. Hansen Holding A/S

Chr. Hansen Holding A/S

Overview
Date Founded

2004

Headquarters

Bøge Allé 10-12,Hørsholm, Capital Region 2970

Type of Company

Public

Employees (Worldwide)

2,852

Industries

Biotechnology

Company Description

Chr. Hansen Holding A/S is a bioscience company, which engages in the development of natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. It operates through the following segments: Food Cultures and Enzymes; Health and Nutrition; and Natural Colors. The Food Cultures and Enzymes segment produces and sells cultures, enzymes, and probiotic products that help determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of consumer products in the food industry. The Health and Nutrition segment manufactures and distributes products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. The Natural Colors segment caters to the food and beverage industry. The company was founded by Christian Ditlev Ammentorp Hansen in 1874 and is headquartered in Hørsholm, Denmark.

Contact Data
Trying to get in touch with decision makers at Chr. Hansen Holding A/S? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer & Executive Vice President

Executive Vice President

Executive Vice President, Food Cultures & Enzymes

Executive Vice President of the Natural Colors Division

Executive Vice President, Global Operations

Executive Vice President & CSO

Executive Vice President, Health & Nutrition

Group Vice President, Americas

Corporate Vice President Compliance & Corporate Affairs

Board of Directors

Vice Chairman at FoodDrinkEurope

Former Executive Vice President & Head of BioPharm & Global Legal & Patents at Novo Nordisk A/S

Former Senior Vice President-Global Foods Research & Development at PepsiCo, Inc.

President & Chief Executive Officer at Coloplast A/S

Former Executive Vice President & Head of Zone EMENA at Nestlé SA

Former Managing Director-Asia, Africa & Middle East at Fonterra Co-operative Group Ltd.

Global Freeze Drying Technology Coordinator at Chr. Hansen Holding A/S

Deputy Chief Executive Officer at Novo Nordisk Fonden

Professional at Chr. Hansen Holding A/S

Director at Chr. Hansen A/S

Paths to Chr. Hansen Holding A/S
Potential Connections via
Relationship Science
You
Chr. Hansen Holding A/S
Owners & Shareholders
Details Hidden

GLG-UK is an active, collaborative manager which aims to achieve consistent superior returns. They adhere to client-focused product development and customer service in both traditional and alternative asset management. The firm's fund managers express their individual investment styles and meet regularly with companies, brokers and consultants, analyzing quantitative models or completing their own proprietary research. They base investment decisions on fundamental research, tactical trading and a wide range of network of industry contacts and employ a rigorous risk management process.

Details Hidden

CCLA is an active, prudent, long-term, GARP-oriented manager which invests in global equity and debt across all market-caps, focusing on UK large-cap growth and value stocks. The firm aims to reduce risk by diversifying geography and asset class and believes that identifying long-term trends and themes is vital. They use third party managers for specialist assets.

Details Hidden

BIAM emphasizes long-term investments, bottom-up stock-picking approach and cash flow analysis. They base their investment process on fundamental research including company visits and extensive use of outsourced industrial expertise from non-financial analysts associated with the sectors in which they invest. The firm invests globally in listed equity, debt and alternative asset classes including private equity. BIAM favors companies with strong cash flow, growth potential within their sector and solid business models. They have specialist expertise in emerging market securities, both equity and fixed income, and invest in the Far East, Latin America and Eastern Europe.

Recent Transactions
Details Hidden

Chr. Hansen Holding A/S purchases UAS Laboratories LLC from Greyrock Capital Group LLC, Lakeview Equity Partners LLC

Details Hidden

Chr. Hansen Holding A/S purchases Österreichische Laberzeugung Hundsbichler GmbH

Details Hidden

Chr. Hansen Holding A/S purchases Valio Oy /LGG Business from Valio Oy

Transaction Advisors
Legal Advisor

Advised onChr. Hansen Holding A/S purchases UAS Laboratories LLC from Greyrock Capital Group LLC, Lakeview Equity Partners LLC

Underwriter

Advised onChr. Hansen Holding A/S issued DKK Ordinary Shares

Underwriter

Advised onChr. Hansen Holding A/S issued DKK Ordinary Shares

Legal Advisor

Advised onChr. Hansen Holding A/S purchases UAS Laboratories LLC from Greyrock Capital Group LLC, Lakeview Equity Partners LLC

Legal Advisor

Advised onChr. Hansen Holding A/S purchases UAS Laboratories LLC from Greyrock Capital Group LLC, Lakeview Equity Partners LLC

Legal Advisor

Advised onChr. Hansen Holding A/S purchases UAS Laboratories LLC from Greyrock Capital Group LLC, Lakeview Equity Partners LLC

Clients

Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded by Benjamin J. Shaw in 2014 and is headquartered in Portland, ME.

Founded in 1982, Neogen Corporation (NASDAQ: NEOG) has grown to more than 600 employees in multiple U.S. and international locations, and a worldwide presence. Neogen develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company’s Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen’s Lexington, Ky.-based Animal Safety Division develops and markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides. Neogen’s GeneSeek subsidiary based in Lincoln, Neb., is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants. Neogen excels at helping to identify safety concerns in the vast and changing landscape of food and animal safety. Neogen sales representatives can help customers address a wide array of concern with a “one-stop shop” approach that is a big advantage in a business climate trending toward single-source suppliers. The company now has more than 200 diagnostic tests to offer customers, and a comprehensive line of complementary products and services, such as dehydrated culture media to go with unmatched customer support and training. Neogen employs a similar marketing strategy for its veterinary products, offering customers a wide variety of animal safety solutions. Neogen believes that maintaining earned trust is a combination of innovation and a continuous commitment to quality. Neogen’s quality management system is ISO 9001 certified, which communicates to the company’s worldwide customer base that it understands the quality standards customers expect, and is firmly committed to achieving those quality standards. In recognition of this success, Neogen has been repeatedly named to Forbes Magazine’s list of the Best Small Companies in America, and was chosen by the NASDAQ National Market to be included in its top tier of listed companies, the Global Select Market.

Genus applies biotechnology to advance the science of animal breeding. As the world leader in improving porcine and bovine stock, we play a crucial role in the global agricultural economy. The progeny of our robust and highly productive pigs and cattle enable Genus customers – farmers and food producers in 70 countries – to meet growing demand for meat and milk despite tightening constraints on resources available for food production.

Key Stats and Financials As of 2020
Market Capitalization
$13.3B
Total Enterprise Value
$16.8B
Earnings Per Share
$2.23
EBITDAMargin
39.81%
Enterprise Value / Sales
14.41x
Enterprise Value EBITDAOperating
36.2x
TEVNet Income
57.07x
Debt TEV
0.1x
Three Year Compounded Annual Growth Rate Of Revenue
-2.88%
Revenue
$1.16B
Net Profit
$294M
EBITDA
$463M
Total Debt
$1.7B
Total Equity
$1.07B
Investors
Details Hidden

Life Peer at United Kingdom House of Lords

Details Hidden

Ardian is an active manager which focuses exclusively on investing in unlisted companies and managing assets on behalf of third parties, aiming to provide long-term returns.The firm invests in buyouts of profitable high-potential companies valued between EUR 100 million and EUR 2 billion, generally taking a controlling interest, aiming to increase their growth and earnings in new markets.Ardian seeks to take controlling interests in small-cap buyouts in France, Germany and Italy, partnering with the investee company to add value and boost growth. They provide expansion capital by investing via minority interests in mature, profitable companies.Their Venture Capital team raises funds and consults innovative high-potential companies in the high-tech life sciences sector, making minority interest investments of EUR 2-5 million after receiving approval from the investment committee.They co-invest in buyout transactions involving companies valued at over EUR 500 million. The investment team constructs a diversified portfolio by sector, country, volume and type of transaction, taking minority interests in major LBOs in Europe and the US.For fund of funds, the firm performs in-house research, including track record, organization, employees and a review of individual assets in the portfolios, aiming to optimize investment in the best North American, European and Asian private equity funds.Ardian makes direct mezzanine investment in Europe as lead, co-investment and minority investor, partnering with other mezzanine funds to promote co-investment deals and increase the regional diversification of their portfolios.Their infrastructure team makes long-term investments of up to EUR 150 million in the transport, energy, water distribution and waste treatment sectors in European companies whose activity generates stable, foreseeable cash-flows.

Details Hidden

PAI is an active manager which focuses their investments on businesses with a strong European presence. The firm makes controlling equity investments in LBOs with transaction values generally between €500 million and several billion euros, aiming to invest in medium- to large-size public or private European companies in the services, consumer goods and capital goods sectors which have market leadership positions and an outstanding management team.PAI partners with their investee companies, aiming to add value by supporting the implementation of strategic and operational improvements, refocusing activities, targeting capital expenditure, marketing and R&D investments, evaluating new business opportunities, identifying add-on acquisitions and utilizing their network of industrial and financial contacts.While the firm participates actively in the key strategic decisions of their investee companies, they leave management in charge of the day-to-day running of the business and offer them attractive equity stakes and competitive performance-based compensation.

Suppliers
Novozymes A/S Other Business & Consulting Services | Copenhagen, Denmark

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.

Arla Foods AmbA Wholesale: Consumer Non-Durables/Sundries | Viby, Denmark

Arla Foods AmbA manufactures and distributes dairy products. The firm produces dairy ingredients and bacterial cultures for food manufacturers and for agricultural use. It offers Lurpak and Castello brands. The company was founded in 1881 and is headquartered in Viby, Denmark.

ADL Bionatur Solutions SA Chemicals | Jerez de la Frontera, Spain

ADL Bionatur Solutions SA operates as a biopharmaceutical company. It develops and produces active therapeutics substances. The company was founded in 2005 and is headquartered in Jerez de la Frontera, Spain.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Chr. Hansen Holding A/S. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Chr. Hansen Holding A/S's profile does not indicate a business or promotional relationship of any kind between RelSci and Chr. Hansen Holding A/S.